Cross Country Healthcare (CCRN)
(Delayed Data from NSDQ)
$13.54 USD
-0.12 (-0.88%)
Updated Sep 19, 2025 04:00 PM ET
After-Market: $13.42 -0.12 (-0.89%) 7:58 PM ET
4-Sell of 5 4
B Value A Growth F Momentum B VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/05/2025
Time: -- |
9/2025 | $0.04 | 0.00% |
Earnings Summary
For their last quarter, Cross Country Healthcare (CCRN) reported earnings of -$0.01 per share, missing the Zacks Consensus Estimate of $0.07 per share. This reflects a negative earnings surprise of 114.29%. Look out for CCRN's next earnings release expected on November 05, 2025. For the next earning release, we expect the company to report earnings of $0.04 per share, reflecting a year-over-year decrease of 66.67%.
Earnings History
Price & Consensus
Zacks News for CCRN
Cross Country Healthcare (CCRN) Reports Q2 Loss, Misses Revenue Estimates
CCRN: What are Zacks experts saying now?
Zacks Private Portfolio Services
Kforce (KFRC) Lags Q2 Earnings Estimates
Analysts Estimate Cross Country Healthcare (CCRN) to Report a Decline in Earnings: What to Look Out for
Cross Country Healthcare (CCRN) Q1 Earnings Top Estimates
CCRN FAQs
Based on past history, Zacks believes Cross Country Healthcare, Inc. (CCRN) will report their next quarter earnings on November 05, 2025. For the next earning release, we expect the company to report earnings of 0.04 per share, reflecting a year-over-year increase of -66.67.
Based on past history, Zacks believes Cross Country Healthcare, Inc. (CCRN) will report their previous quarter earnings %%TIME_OF_DAY_CODE%% on November 05, 2025.
The Zacks Consensus Estimate for Cross Country Healthcare, Inc. (CCRN) for the quarter ending September 2025 is $0.04 a share. We expect Cross Country Healthcare, Inc. (CCRN) to report earnings in line with the consensus estimate of $0.04 per share
In the earnings report for the quarter ending in June 2024, Cross Country Healthcare, Inc. (CCRN) announced earnings of $0.10 per share versus the Zacks Consensus Estimate of $0.14 per share, representing a surprise of -28.57%.